Home › Calculator › RADX Dividend Calculator 2026
RADX Dividend DRIP Calculator 2026
46.73% YieldHealthcareRadiopharm Theranostics Limited · NASDAQ
Price: $4.28 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When RADX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your RADX snowball 📈
$10,000 in RADX → $15.81M in 10 years · $601.12/month
About Radiopharm Theranostics Limited (RADX) — Dividend Analysis 2026
Radiopharm Theranostics Limited, an Australian company established in Carlton in 2021, specializes in the research and development of cutting-edge radiopharmaceutical treatments. Their mission is to address critical gaps in healthcare by creating products for both diagnostic imaging and therapeutic intervention across a spectrum of challenging medical conditions. The company's diverse pipeline features: RAD 204, designed to target PD-L1 for non-small cell lung cancer; RAD 202, aimed at HER2 for breast cancer and other solid tumor types; and two avß6 integrin-targeting agents, RAD 301 (a diagnostic tool for pancreatic ductal adenocarcinoma) and RAD 302 (a therapeutic agent for various cancers). Other significant developments include RAD 101 and RAD 102 for brain metastases, RAD 402 for advanced prostate cancer, and RV01 for multiple solid tumors. To accelerate the clinical progression of its radiopharmaceutical assets, Radiopharm Theranostics maintains a strategic partnership with Lantheus Holdings, Inc.
Compare RADX with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full RADX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open RADX position with:
🌍 RADX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold RADX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 46.73% | 43.93% | $4,673 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 39.72% | 36.92% | $3,972 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 37.38% | 34.58% | $3,738 / yr |
| 🇬🇧 UK ISA | 0% | 46.73% | 43.93% | $4,673 / yr |
| 🇬🇧 UK Taxable | 8.75% | 42.64% | 39.84% | $4,264 / yr |
| 🇨🇦 TFSA | 0% | 46.73% | 43.93% | $4,673 / yr |
| 🇨🇦 CA Taxable | 25% | 35.05% | 32.25% | $3,505 / yr |
| 🇦🇺 Super (pension) | 15% | 39.72% | 36.92% | $3,972 / yr |
| 🇦🇺 AU Taxable | 30% | 32.71% | 29.91% | $3,271 / yr |
| 🇩🇪 DE Taxable | 26.375% | 34.40% | 31.60% | $3,440 / yr |
| 🇫🇷 FR Taxable | 30% | 32.71% | 29.91% | $3,271 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 RADX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 RADX Dividend Payment Schedule
RADX pays quarterly — 4 times per year. Next ex-div: TBD.
📊 RADX vs Healthcare Benchmarks
How RADX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RADX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ RADX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Other | 2028-07-01 | 7,657,334 | $0.03 | $191.4K | ||
| Other | 2028-07-01 | 6,048,542 | $0.03 | $151.2K | ||
| Other | 2024-09-13 | 27,500,000 | $0.06 | $1.65M | ||
| Other | 2025-07-01 | 1,403,723 | $0.17 | $238.6K | ||
| Other | 2022-11-25 | 3,571,428 | $0.20 | $714.3K | ||
| Other | 2022-11-25 | 17,857 | $0.20 | $3.6K | ||
| Other | 2026-03-18 | 5,333,333 | $0.06 | $320.0K | ||
| Other | 2026-03-18 | 2,693,603 | $0.04 | $110.4K | ||
| Other | 2026-03-18 | 6,814,000 | $0.03 | $170.3K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Geographic Revenue Breakdown
Where RADX earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RADX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Radiopharm Theranostics Limited (RADX) is currently trading at $4.28, 76% below its 52-week high. The current dividend yield is 46.73% based on an annual payout of $2.00 per share.
RADX (Radiopharm Theranostics Limited) — 46.73% Dividend Yield Analysis
Radiopharm Theranostics Limited (RADX) is a healthcare stock currently trading at $4.28 with a dividend yield of 46.73%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (46.73%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.